Roel Schaapveld, the Chief Operating Officer of InteRNA Technologies, will give a presentation on BioBusiness Event 2009. As COO Roel is responsible for InteRNA's day-to-day operations and to develop its strategy and opportunities for further development. InteRNA Technologies aims to translate its proprietary miRNA discovery technologies and new miRNA molecules into successful diagnostic and therapeutic applications to improve treatment of cancer. Prior to InteRNA Roel was senior manager in the corporat
e finance biotech team at Dutch merchant bank Kempen & Co. Previously, he held several positions at KREATECH Biotechnology, among which VP Corporate and Business Development. Roel holds a M.Sc. in Molecular Biology and received his Ph.D. from the University of Nijmegen, the Netherlands. During his academic career he worked at the Roche Institute for Molecular Biology (Nutley, NJ), at the Dana-Farber Cancer Institute (Boston, MA) and at the Netherlands Cancer Institute in Amsterdam. Roel received his MBA from Nyenrode Business School, The Netherlands.
InteRNA Technologies B.V. actively explores and exploits opportunities to translate its unique collection of microRNAs (miRNAs) and miRNA discovery and validation technologies into successful diagnostic, prognostic and therapeutic applications. The Company focuses on the development of innovative miRNA-based therapeutics for cancer.
Return










